Medical News

RSS

Insight into role of cytokines in autoimmune diseases

Cytokines, a varied group of signaling chemicals in the body, have been described as the software that runs the immune system, but when that software malfunctions, dysregulation of the immune system can result in debilitating autoimmune diseases such as lupus, arthritis, and diabetes. Leading experts in the field of cytokine research present their most up-to-date findings and unique perspectives on the role of cytokines in autoimmune diseases in a special issue of Journal of Interferon & Cytokine Research, a peer-reviewed publication of Mary Ann Liebert, Inc.

28 Oct 2011

Special team care reduces cumulated stroke risk after transient ischaemic attacks

Patients who had a transient ischaemic attack (TIA), sometimes referred to as a "mini stroke", were much less likely to experience further vascular events in the first year if their care was co-ordinated by a special hospital team. That is the key finding from a study published in the November issue of the European Journal of Neurology.

28 Oct 2011

Beneficial intestinal bacteria can activate immune cells and trigger MS

Multiple sclerosis is caused by a combination of genetic and environmental factors. For a long time, pathogens were believed to be such external influences. According to scientists from the Max Planck Institute of Neurobiology in Martinsried, however, it is apparently not harmful bacteria that trigger multiple sclerosis, but beneficial ones - specifically, the natural intestinal flora, which every human being needs for digestion.

28 Oct 2011

Taking regular aspirin halves risk of hereditary cancers

Scientists including those from Queen's University have discovered that taking regular aspirin halves the risk of developing hereditary cancers.

28 Oct 2011

Study reveals smaller teeth in premature children

The size of teeth in premature children is smaller. This has been established in a study from the Faculty of Odontology at Malmö University in Sweden.

28 Oct 2011

Viewpoints: Gephardt and Leavitt's bipartisan push for biomedical innovation; suggestions for the super committee

We Americans are rightfully proud of our can-do spirit. We know that our nation is capable of uniting for a common goal - and triumphing. In this time of economic challenge and political divisiveness, we are proposing an idea for our country's next common mission: biomedical innovation. From our combined decades of experience leading in the Congress and the U.S. Department of Health and Human Services, we see the biomedical frontier as America's greatest opportunity to align our nation's competencies and resources for a better future.

28 Oct 2011

Foreign aid investment saves millions of lives, reflects American leadership

Chris Collins, vice president and director of public policy at the Foundation for AIDS Research (amfAR), and Khai Hoan Tram, an Allan Rosenfield Fellow at amfAR, write in this Huffington Post opinion piece that what's missing from the discussion of foreign aid -- which accounts for approximately one percent of the U.S. national budget -- "is the fact that [it] is actually used to aid those in need while advancing our country's humanitarian and diplomatic goals.

28 Oct 2011

Enoxaparin can reduce risk of VTE in plastic surgery patients

For plastic surgery patients at high risk, treatment with the anticoagulant (blood-thinning) drug enoxaparin can reduce the risk of serious blood clot-related complications called venous thromboembolism (VTE), reports a study in the November issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

28 Oct 2011

Nipple sparing mastectomy safe and effective option for breast cancer treatment

A new study suggests some women needing a lumpectomy or mastectomy to treat their breast cancer have another potential option that is safe and effective, say researchers at Georgetown. They say the procedure known as a nipple sparing mastectomy is also a viable surgical option for women who choose to have their breasts removed because of their increased risk of developing the disease.

28 Oct 2011

Diabetic patients with mild kidney disease may benefit from vitamin B6 derivative

A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.

28 Oct 2011

Million Hearts' goal to prevent a million heart attacks and strokes in five years

In the time needed to read out loud the headline on this story, someone has died from a stroke. Every 6 seconds, someone in the world dies from stroke. The Centers for Disease Control and Prevention, in support of World Stroke Day, Oct. 29, 2011, asks Americans to take immediate action to reduce their risk for stroke.

28 Oct 2011

La Jolla Institute becomes 5th participant in novel stem cell research collaboration

The La Jolla Institute for Allergy & Immunology has become the fifth organization in the prestigious Sanford Consortium for Regenerative Medicine, joining colleagues from the Salk Institute for Biological Studies, The Scripps Research Institute, University of California, San Diego and the Sanford-Burnham Medical Research Institute in the first-of-its-kind multi-institutional stem cell research collaboration.

28 Oct 2011

Gilead submits Quad NDA to FDA for treatment of HIV-1 infection

Gilead Sciences, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of the "Quad", a complete single-tablet regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate for the treatment of HIV-1 infection in adults.

28 Oct 2011

ZEISS launches PhotoFusion lenses for people of all ages

Up to 40 percent of eyeglass wearers are interested in self-tinting lenses, according to an international Carl Zeiss Vision study of 5,800 eyeglass wearers. Yet despite high consumer interest, only about 20 percent of eyeglass wearers purchase self-tinting lenses. Many consumers hold back because they want lenses that darken and clear faster. To meet this need, ZEISS, a leader in precision optics for over 160 years, has introduced a new self-tinting lens called PhotoFusion.

28 Oct 2011

Regeneron announces positive results from sarilumab Phase 2b trial on RA

Regeneron Pharmaceuticals, Inc. today announced that detailed clinical data from the positive Phase 2b portion of the seamless Phase 2/3 MOBILITY trial of sarilumab in rheumatoid arthritis (RA) will be presented at a late-breaking poster session at the upcoming American College of Rheumatology (ACR) Annual Scientific Meeting, which will take place from November 5-9 in Chicago.

28 Oct 2011

Apnex Medical's HGNS System receives CE Mark approval for treatment of OSA

Apnex Medical, Inc., has received CE Mark approval for its Hypoglossal Nerve Stimulation System for use by people who suffer from obstructive sleep apnea.

28 Oct 2011

TU/e researcher develops smart eye-surgery robot

Researcher Thijs Meenink at Eindhoven University of Technology (TU/e) has developed a smart eye-surgery robot that allows eye surgeons to operate with increased ease and greater precision on the retina and the vitreous humor of the eye.

28 Oct 2011

Roundup: Mass. offers plan to cut costs for dual eligibles; Oregon's high hopes for coordinated care organizations

The governor of Massachusetts wants to hire private insurers or other third parties to manage care for the poor and chronically ill patients who use a disproportionate share of public health-care dollars. The proposal comes as state and federal officials search for a cheaper way to deliver health care to people known as "dual eligibles." These are the 9.2 million in the U.S. who receive both Medicare, the federal program for those 65 and older or disabled, and Medicaid, the joint state-federal health plan for the poor.

28 Oct 2011

Bottom-line boost for Australian Biotechs

Biotechnology companies and international investors are reporting excellent results from this year’s AusBiotech conference, with programs and activities dedicated to helping companies and researchers connect with investors and partners, stirring substantial international interest.

27 Oct 2011

Novel scarless surgery effectively removes skull base tumors

A technique developed by Johns Hopkins surgeons is providing a new route to get to and remove tumors buried at the base of the skull: through the natural hole behind the molars, above the jawbone and beneath the cheekbone.

27 Oct 2011